Nanoform Finland Oyj (HEL:NANOFH)

Market Cap	105.72M
Revenue (ttm)	3.95M
Net Income (ttm)	-22.54M
Shares Out	85.67M
EPS (ttm)	-0.26
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	178,396
Average Volume	236,859
Open	1.266
Previous Close	1.216
Day's Range	1.200 - 1.266
52-Week Range	0.724 - 1.820
Beta	0.61
RSI	65.85
Earnings Date	Nov 12, 2025

About Nanoform Finland Oyj

Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) nanoparticles directly from solution; biological nanoforming technology; and flexible dosage forms of nanoformed drug substances. It also offers STARMAP,...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 181
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: NANOFH

Financial Performance

In 2024, Nanoform Finland Oyj's revenue was 3.66 million, an increase of 42.70% compared to the previous year's 2.57 million. Losses were -23.43 million, 12.9% more than in 2023.